載入...
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide on Research Studies in the United States
PURPOSE: Novel agents are currently combined with radiation and temozolomide (RT+TMZ) in newly diagnosed glioblastoma using overall survival as the primary endpoint. Results of these phase II studies are typically compared to the phase III EORTC survival data that resulted in RT+TMZ becoming standar...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2861898/ https://ncbi.nlm.nih.gov/pubmed/20371685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-3106 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|